treatment of Dysmenorrhea with Unani medicine

Effect of majoon Musakkin Dard Rahim in Primary Dysmenorrhea (usr al tamth oola) A Randomized Control Study

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/078915

Enrollment

Registered

2025-01-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Ma?jun Musakkin Dard Rahim: 6gm orally twice daily will be given from 2 days before menstruation to 3 days during menstruation for three consecutive cycles. Control Intervention1: Palce

Eligibility

Inclusion criteria

Inclusion criteria: Study participants with, Painful menstruation from day one of menstrual cycle, Regular Menstrual Cycle Age between 15-35 years and VAS = 4

Exclusion criteria

Exclusion criteria: Study participants with,Heavy menstrual bleeding and severe anaemia, Pelvic pathology like uterine fibroid, adenomyosis, endometriosis, PID,Any systemic co-morbidities like Diabetes mellitus, hypertension, IUCD insertion.

Design outcomes

Primary

Measure	Time frame
Improvement in VAS score and VMSS gradingTimepoint: Base line, every month for 3 consecutive months.	—

Secondary

Measure	Time frame
reduction in uterine artery doppler indices such as PI, RI, S/D ratioTimepoint: baseline & after 3months	—

Countries

India

Contacts

Public ContactDr KOUSER FATHIMA FIRDOSE

National Institute of unani medicine

kouser2fathima@gmail.com09141762284

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026